200714-22-3 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indole, 7-fluoro-3-(1,2,3,6-tetrahydro-4-pyridinyl)is used as a pharmaceutical candidate for the development of drugs targeting various therapeutic applications. Its unique structure and potential pharmacological properties make it a valuable compound for research and development in the pharmaceutical field.
Used in Drug Discovery and Development:
1H-Indole, 7-fluoro-3-(1,2,3,6-tetrahydro-4-pyridinyl)is employed as a starting point for drug discovery and development. Its indole-based structure and fluorine substitution provide opportunities for further chemical modifications and optimization to enhance its pharmacological properties and therapeutic potential.
Used in Medicinal Chemistry Research:
1H-Indole, 7-fluoro-3-(1,2,3,6-tetrahydro-4-pyridinyl)serves as a valuable compound in medicinal chemistry research. Its unique structure allows for the exploration of structure-activity relationships and the identification of novel pharmacological targets, contributing to the advancement of drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 200714-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,0,7,1 and 4 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 200714-22:
(8*2)+(7*0)+(6*0)+(5*7)+(4*1)+(3*4)+(2*2)+(1*2)=73
73 % 10 = 3
So 200714-22-3 is a valid CAS Registry Number.
200714-22-3Relevant articles and documents
1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake
-
, (2008/06/13)
The pharmaceutical use of novel compounds of formula I: where Z is a structure of formula A-B is -C=CH- or -C(R5)-CH2-; X is S or NR4; R1is H, halo, formyl, C1-C4alkyl, C1-C4alkoxy, thienylmethyloxy, 4,5-dihydrothiazol-2-yl, cyano, nitro, carboxamido, trifluoromethyl or hydroxy; R2is H or halo; R3is H, C1-C4alkyl, (C1-C4alkylene)-aryl, or -CH2-Y-NR7R8; R4is H, C1-C4alkyl, C1-C5acyl, or phenylsulfonyl; R5is H or OH; R6is H or methyl; Y is -CH2- or -C(O)-; R7is pyridinyl; and R8is H or -C(O)-(C3-C6cycloalkyl); and pharmaceutically acceptable salts thereof.
